HOME › DRUGS › CRIZOTINIB
ACTIVE SUBSTANCE / INN

CRIZOTINIB

Brand name(s): Xalkori, XALKORI
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Carcinoma, Non-Small-Cell Lung
NDA217581
ACTIVE SUBSTANCE
Crizotinib
REGULATORS
FDA · EMA
SPONSORS / MAH
PF PRISM CV, Pfizer Europe MA EEIG
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
XALKORINDA217581PF PRISM CVPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
XalkoriPfizer Europe MA EEIGAuthorised23/10/2012Carcinoma, Non-Small-Cell Lung

FULL INTELLIGENCE ON CRIZOTINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →